Detalhe da pesquisa
1.
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
Oncologist
; 28(3): 252-257, 2023 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36718018
2.
Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer.
Gynecol Oncol
; 162(3): 661-666, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34243976
3.
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Cancer
; 122(21): 3297-3306, 2016 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27421044
4.
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.
Int J Gynecol Cancer
; 24(9): 1583-9, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25254563
5.
Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
Int J Gynecol Cancer
; 23(7): 1219-25, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23975042
6.
Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.
J Natl Cancer Inst
; 115(7): 831-837, 2023 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37074956
7.
Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone.
Gynecol Oncol
; 127(1): 161-7, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22765965
8.
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Cancer Chemother Pharmacol
; 89(3): 423-430, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35142863
9.
Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.
Gynecol Oncol
; 116(2): 168-72, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19922985
10.
Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
Int J Clin Oncol
; 15(4): 390-8, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20405155
11.
Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
J Allergy Clin Immunol
; 123(6): 1262-7.e1, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19501233
12.
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
Gynecol Oncol
; 112(2): 394-9, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19058838
13.
A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology.
Gynecol Oncol
; 115(3): 443-6, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19804902
14.
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy.
Pediatr Blood Cancer
; 50(5): 1060-2, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-17914739
15.
Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
Obstet Gynecol
; 105(5 Pt 1): 1006-11, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15863537
16.
Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis.
N Engl J Med
; 354(15): 1615-25, 2006 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-16611953
17.
Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials.
Med Oncol
; 30(1): 435, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23397080
18.
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis.
Eur J Cancer
; 48(15): 2361-8, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22541893
19.
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
Clin Ovarian Cancer Other Gynecol Malig
; 4(1): 26-33, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21833345
20.
Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.
J Clin Oncol
; 28(1): 154-9, 2010 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19917843